-
-
Peptide Name
- GnRH-III(4Ser,8Lys (DaudAoa)
-
Source
- Synthetic construct
-
-
-
-
-
UniProt Entry
-
No entry found
-
Protein Existence
- Not found
-
Biological Activity
- Anti-cancer
-
Target Organism
-
No LC50s found in DRAMP database
-
Hemolytic Activity
-
- No hemolysis information or data found in the reference(s) presented in this entry
-
Cytotoxicity
-
- [Ref.21668011]IC50=6.5±1.8 μM against MCF-7 human breast cell lines, IC50=27.8±5.4 μM against HT-29 human colon cell lines, IC50=6.1±2.1 μM against LNCaP human prostate cancer cell lines .
-
-
Serum or Protease Type
- Trypsin, ?-chymotrypsin, and pepsin
-
Stability Data
- All bioconjugates showed high stability in the presence of pepsin even after 24 h of incubation, as no proteolytic fragmentswere identified by LC-MS
-
-
-
N-terminal Modification
- Free
-
C-terminal Modification
- Free
-
Nonterminal Modifications and Unusual Amino Acids
- K(8)=(Dau=Aoa)
-
-
-
Structure Description
- Not found
-
-
-
There is no predicted structure for DRAMP29919.
- ·Literature 1
-
Title
- Enhanced enzymatic stability and antitumor activity of daunorubicin-GnRH-III bioconjugates modified in position 4.
-
-
Reference
- Bioconjug Chem. 2011 Jul 20;22(7):1320-9.
-
Author
- Manea M, Leurs U, Orbán E, Baranyai Z, Öhlschläger P, Marquardt A, Schulcz Á, Tejeda M, Kapuvári B, Tóvári J, Mezo G.